What Shkreli did was unusual, for a number of reasons. But he isn’t as much of an outlier as the drug industry would like us to think.
“If we have a financial incentive to believe something or conclude something, we kind of trick ourselves into thinking it’s true,” he said. “And we’re not always aware we’re doing it.”
U.S. doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data on the financial links between the companies and the people who prescribe their products. The data released Tuesday range from the royalties paid to